Published in J R Soc Med on February 01, 2013
Personalizing health care: feasibility and future implications. BMC Med (2013) 1.07
Personalised medicine and National Health Service culture. J R Soc Med (2013) 0.75
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ (2004) 21.39
Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med (2009) 12.63
Clinical assessment incorporating a personal genome. Lancet (2010) 10.18
Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med (2008) 9.64
Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med (2011) 6.90
CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis. JAMA (2011) 5.93
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther (2011) 4.42
Bridging the efficacy-effectiveness gap: a regulator's perspective on addressing variability of drug response. Nat Rev Drug Discov (2011) 1.58
Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance. Expert Rev Pharmacoecon Outcomes Res (2009) 1.28
Pharmacogenetics in drug discovery and development: a translational perspective. Nat Rev Drug Discov (2008) 1.23
Personalized medicine. New cystic fibrosis drug offers hope, at a price. Science (2012) 1.10
Hospitalization costs associated with warfarin-related bleeding events among older community-dwelling adults. Pharmacoepidemiol Drug Saf (2010) 1.04
Insight into recent reforms and initiatives in Austria: implications for key stakeholders. Expert Rev Pharmacoecon Outcomes Res (2008) 0.98
The clinical utility of precision medicine: properly assessing the value of emerging diagnostic tests. Clin Pharmacol Ther (2010) 0.86
The Iranian health insurance system; past experiences, present challenges and future strategies. Iran J Public Health (2012) 3.28
Cost effectiveness of treatment for gastro-oesophageal reflux disease in clinical practice: a clinical database analysis. Gut (1998) 2.97
Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol (1983) 2.59
Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials. Diabetologia (2012) 2.53
HIV prevalence and risk behaviours for HIV transmission in South Australian prisons. AIDS (1991) 2.30
Heroin overdose: the case for take-home naloxone. BMJ (1996) 2.25
Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease - evidence from systematic reviews of randomized controlled trials (second update, January 2006). J Hum Nutr Diet (2006) 2.09
Hyperalgesic responses in methadone maintenance patients. Pain (2001) 2.09
Economics of myocardial perfusion imaging in Europe--the EMPIRE Study. Eur Heart J (1999) 2.01
Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev (2008) 1.79
Adverse effects of extradural and intrathecal opiates: report of a nationwide survey in Sweden. Br J Anaesth (1982) 1.77
Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. Addiction (1998) 1.75
Randomised controlled trial comparing an acute paediatric hospital at home scheme with conventional hospital care. Arch Dis Child (2002) 1.72
Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania. J Clin Pharm Ther (2003) 1.71
Assessing health worker performance in malaria case management of underfives at health facilities in a rural Tanzanian district. Trop Med Int Health (2007) 1.64
Pentamidine concentrations in plasma, whole blood and cerebrospinal fluid during treatment of Trypanosoma gambiense infection in Côte d'Ivoire. Trans R Soc Trop Med Hyg (1992) 1.63
Diagnostic utility of flumazenil in coma with suspected poisoning: a double blind, randomised controlled study. BMJ (1990) 1.62
Alpha2 adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev (2004) 1.59
Nutritional survey of Bangladeshi children aged under 5 years in the London borough of Tower Hamlets. Arch Dis Child (1983) 1.56
Nipah virus infection among abattoir workers in Malaysia, 1998-1999. Int J Epidemiol (2001) 1.54
An integrated national pharmaceutical policy for the United Kingdom? BMJ (2000) 1.48
Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation. Health Technol Assess (2003) 1.46
Bacillus spp. among hospitalized patients with haematological malignancies: clinical features, epidemics and outcomes. J Hosp Infect (2006) 1.44
The analgesic effect of racemic ketamine in patients with chronic ischemic pain due to lower extremity arteriosclerosis obliterans. Acta Anaesthesiol Scand (1998) 1.40
The impact of health economics on healthcare delivery: the health economists' perspective. Pharmacoeconomics (2001) 1.39
Health care financing in iran; is privatization a good solution? Iran J Public Health (2012) 1.38
Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev (2004) 1.35
Ethics and pharmaceutical medicine -- the full report of the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK. Int J Clin Pract (2006) 1.34
On the question of dose-dependent chloroquine elimination of a single oral dose. Clin Pharmacol Ther (1983) 1.34
The abbreviated impactor measurement (AIM) concept: part 1--Influence of particle bounce and re-entrainment-evaluation with a "dry" pressurized metered dose inhaler (pMDI)-based formulation. AAPS PharmSciTech (2009) 1.34
A review of biological indicators of illicit drug use, practical considerations and clinical usefulness. Addiction (1999) 1.32
Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation. Health Technol Assess (2004) 1.26
HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges. Med J Aust (1997) 1.26
Guiding Principles for Pharmaceutical Physicians from the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK. Int J Clin Pract (2006) 1.25
Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev (2006) 1.23
Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort. Neurology (2011) 1.22
Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol (2003) 1.22
Pharmacoeconomics: basic concepts and terminology. Br J Clin Pharmacol (1997) 1.22
Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Syst Rev (2005) 1.21
Characterization of chloroquine plasma protein binding in man. Br J Clin Pharmacol (1983) 1.21
Coronary artery stents: a rapid systematic review and economic evaluation. Health Technol Assess (2004) 1.18
Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev (2004) 1.18
The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature. Health Econ (2001) 1.16
The aging paradox: free radical theory of aging. Exp Gerontol (1999) 1.15
Increased intraocular pressure on the first postoperative day following resident-performed cataract surgery. Eye (Lond) (2011) 1.14
Relationship between circulating levels of IFN-gamma, IL-10, CXCL9 and CCL2 in pulmonary and extrapulmonary tuberculosis is dependent on disease severity. Scand J Immunol (2009) 1.13
Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype. Clin Pharmacol Ther (1998) 1.12
The abbreviated impactor measurement (AIM) concept: part II--Influence of evaporation of a volatile component-evaluation with a "droplet-producing" pressurized metered dose inhaler (pMDI)-based formulation containing ethanol as cosolvent. AAPS PharmSciTech (2009) 1.12
Present state of extradural and intrathecal opioid analgesia in Sweden. A nationwide follow-up survey. Br J Anaesth (1987) 1.11
Binding of monoclonal anti-native DNA autoantibodies to DNA of varying size and conformation. Mol Immunol (1985) 1.10
Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials. Am J Gastroenterol (1996) 1.10
Drug-eluting stents: a systematic review and economic evaluation. Health Technol Assess (2007) 1.10
A strategy for reducing maternal mortality. Bull World Health Organ (1999) 1.09
Allergy in systemic lupus erythematosus. IgE levels and reaginic phenomenon. Arthritis Rheum (1976) 1.07
Alpha2 adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev (2001) 1.06
Whole exome sequencing unravels disease-causing genes in consanguineous families in Qatar. Clin Genet (2013) 1.06
CYP3A5 genotype has an impact on the metabolism of the HIV protease inhibitor saquinavir. Clin Pharmacol Ther (2007) 1.05
Chloroquine and desethylchloroquine in plasma, serum, and whole blood: problems in assay and handling of samples. Ther Drug Monit (1985) 1.05
A review of telemedicine cost-effectiveness studies. J Telemed Telecare (2000) 1.05
Clinical experience of long-term treatment with epidural and intrathecal opioids--a nationwide survey. Acta Anaesthesiol Scand (1988) 1.04
Clinical diagnosis of malaria and the risk of chloroquine self-medication in rural health centres in Burkina Faso. Trop Med Int Health (2008) 1.04
International variability in the reimbursement of cancer drugs by publically funded drug programs. Curr Oncol (2012) 1.04
High-performance liquid chromatographic method for determination of amodiaquine, chloroquine and their monodesethyl metabolites in biological samples. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 1.03
Subcutaneous metallic mercury injection of the hand. Br J Plast Surg (2003) 1.02
Recruitment difficulties in a home telecare trial. J Telemed Telecare (2006) 1.01
Effectiveness of a community intervention on malaria in rural Tanzania - a randomised controlled trial. Afr Health Sci (2010) 1.00
Economic evaluation of an acute paediatric hospital at home clinical trial. Arch Dis Child (2002) 0.99
Cokeromyces recurvatus, a mucoraceous zygomycete rarely isolated in clinical laboratories. J Clin Microbiol (1994) 0.99
Linkage mapping around the ragged (Ra) and wasted (wst) loci on distal mouse chromosome 2. Genomics (1994) 0.98
Antibodies from patients with mixed connective tissue disease react with heterogeneous nuclear ribonucleoprotein or ribonucleic acid (hnRNP/RNA) of the nuclear matrix. J Immunol (1984) 0.98
Evaluation of three qualitative tests for detection of chloroquine in urine--agreement with plasma concentrations determined with liquid chromatography. Ann Trop Med Parasitol (1986) 0.98
Reliability of Dill-Glazko test. Lancet (1985) 0.97
Emergency medicine in China: redefining a specialty. J Emerg Med (2001) 0.97
Expansion in size of a terminal deletion: a paradigm shift for parental follow-up studies. J Med Genet (2008) 0.97
Patient and provider perspectives on home telecare: preliminary results from a randomized controlled trial. J Telemed Telecare (2005) 0.96
Pharmacokinetics of quinine and its metabolites in pregnant Sudanese women with uncomplicated Plasmodium falciparum malaria. J Clin Pharm Ther (2007) 0.96
Bloody needles: the volumes of blood transferred in simulations of needlestick injuries and shared use of syringes for injection of intravenous drugs. AIDS (1991) 0.96
Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortriptyline and other tricyclic antidepressants. Ther Drug Monit (1985) 0.95
Alpha2 adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev (2003) 0.95
Comparative physiology of salt tolerance in Candida tropicalis and Saccharomyces cerevisiae. Microbiology (1997) 0.93
Medication errors in primary care in Riyadh City, Saudi Arabia. East Mediterr Health J (2011) 0.93
Polyamine induced Z-conformation of native calf thymus DNA. FEBS Lett (1995) 0.92
Nipah virus among military personnel involved in pig culling during an outbreak of encephalitis in Malaysia, 1998-1999. Emerg Infect Dis (2001) 0.92
Severe bone marrow necrosis without suggestive features. Am J Hematol (2006) 0.92
Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers. Clin Pharmacol Ther (1995) 0.91
Methadone, ciprofloxacin, and adverse drug reactions. Lancet (2000) 0.91
The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quinine in vivo. Clin Pharmacol Ther (1999) 0.91
Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotype. Pharmacogenetics (1999) 0.91
A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence. Drug Alcohol Depend (2013) 0.90
Benign copy number changes in clinical cytogenetic diagnostics by array CGH. Cytogenet Genome Res (2009) 0.90
Pharmacokinetic interactions between chloroquine, sulfadoxine and pyrimethamine and their bioequivalence in a generic fixed-dose combination in healthy volunteers in Uganda. Afr Health Sci (2006) 0.90
Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activity. Pharmacogenetics (2001) 0.90
Hepatitis C and the history of injecting drug use in South Australia. Med J Aust (1994) 0.90
Adverse drug reactions in patients admitted on internal medicine wards in a district and regional hospital in Uganda. Afr Health Sci (2011) 0.89
Accounting for noncompliance in pharmacoeconomic evaluations. Pharmacoeconomics (2001) 0.88
Lack of effect of chloroquine on the debrisoquine (CYP2D6 and S-mephenytoin (CYP2C19) hydroxylation phenotypes. Br J Clin Pharmacol (1996) 0.88
'Bare below the elbows' and quality of hand washing: a randomised comparison study. J Hosp Infect (2009) 0.88
Measurement and significance of 3-nitrotyrosine in systemic lupus erythematosus. Scand J Immunol (2006) 0.88
Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies. Health Technol Assess (2006) 0.88